DR. MARY ANN CHEN SHUI, O.D.
Optometry in San Jose, CA
License number
California 11806T
Category
Optometry
Type
Optometrist
Address
Address
2
1101 S Winchester Blvd Suite E-156, San Jose, CA 95128
45584 Cherokee Ln, Fremont, CA 94539
45584 Cherokee Ln, Fremont, CA 94539
Phone
(408) 244-8700
(408) 244-9560 (Fax)
(408) 278-2020
(408) 244-9560 (Fax)
(408) 278-2020
Personal information
See more information about MARY ANN CHEN SHUI at radaris.comName
Address
Phone
451 Hyde St APT 7, San Francisco, CA 94109
41063 Bernie St, Fremont, CA 94539
4065 Lynd Ave, Arcadia, CA 91006
4101 Hanford St, Union City, CA 94587
524 E Warren Ave, Fremont, CA 94539
Professional information
See more information about MARY ANN CHEN SHUI at trustoria.com
Customer Service Representative At Sb Freight
Customer Service Representative At Sb Freight
Position:
Customer Service Representative at SB Freight, Part-time Assistant (Saturdays) at ZUZAI Eye-Q Store
Location:
Fremont, California
Industry:
Accounting
Work:
SB Freight
- FREMONT since Apr 2012
-
Customer Service Representative
ZUZAI Eye-Q Store
- Fremont since Jun 2007
-
Part-time Assistant (Saturdays)
VITA.
- Fremont ( Volunteer Income Tax Assistance) Jan 2012 - Apr 2012
-
Assistance (VITA)
ProNet Career Center-EDD, (Volunteer)
- Fremont Jan 2012 - Feb 2012
-
Member
Comchip Technology Corporation
- Fremont, CA Apr 2010 - May 2011
-
Bookkeeping A/P, A/R
ProNet networking organization
- Fremont CA Jan 2009 - Feb 2010
-
Staffed Marketing Researcher team (volunteer members)
Acme Micro Systems, Fremont, California
- Fremont , CA Mar 2006 - Nov 2008
-
Bookkeeper/AR
Behavior Tech Computer Corp
- Fremont, CA Feb 1999 - Mar 2006
-
RMA Clerk
Education:
AMFASOFT Corporation 2010 - 2010
Certificate of Completion, Computerized Accounting/Bookkeepingn American Institute of Professional Bookkeeper 2010 - 2010
Certificate of Completion, Mastering payroll Ohlone College 2002 - 2004
Associate Degree, Business Accounting Ohlone College 2000 - 2002
Certificate of Completion, Computerized Accounting/Bookkeepingn American Institute of Professional Bookkeeper 2010 - 2010
Certificate of Completion, Mastering payroll Ohlone College 2002 - 2004
Associate Degree, Business Accounting Ohlone College 2000 - 2002
Languages:
Mandarin
Dr. Mary Chen, Fremont CA - MD (Doctor of Medicine)
Dr. Mary Chen, Fremont CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
2500 Mowry Ave SUITE 212, Fremont 94538
(510) 608-6174 (Phone), (510) 745-6435 (Fax)
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (650) 325-7912 (Fax)
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (650) 853-2966 (Fax)
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (510) 208-1776 (Fax)
(510) 608-6174 (Phone), (510) 745-6435 (Fax)
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (650) 325-7912 (Fax)
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (650) 853-2966 (Fax)
PALO ALTO MEDICAL FOUNDATION
795 El Camino Real, Palo Alto 94301
(650) 321-4121 (Phone), (510) 208-1776 (Fax)
Certifications:
Internal Medicine, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Med Coll Of Pa
Graduated: 1979
Med Coll Of Pa
Graduated: 1979
Diagnostic Markers And Pharmacological Targets In Heart Failure And Related Reagents And Methods Of Use Thereof
Diagnostic Markers And Pharmacological Targets In Heart Failure And Related Reagents And Methods Of Use Thereof
US Patent:
2005015, Jul 14, 2005
Filed:
May 21, 2004
Appl. No.:
10/850941
Inventors:
Euan Ashley - Palo Alto CA, US
Mary Chen - Fremont CA, US
Thomas Quertermous - Stanford CA, US
David Xing-Fei Deng - Mountain View CA, US
Anya Tsalenko - Chicago IL, US
Amir Ben-dor - Bellevue WA, US
Laurakay Bruhn - Mountain View CA, US
Zohar Yakhini - Ramat HaSharon, IL
Mary Chen - Fremont CA, US
Thomas Quertermous - Stanford CA, US
David Xing-Fei Deng - Mountain View CA, US
Anya Tsalenko - Chicago IL, US
Amir Ben-dor - Bellevue WA, US
Laurakay Bruhn - Mountain View CA, US
Zohar Yakhini - Ramat HaSharon, IL
International Classification:
A61K051/00, C12Q001/68, G01N033/53, G01N033/567, C07K016/46
US Classification:
424001490, 435006000, 435007200, 530391100
Abstract:
The invention identifies genes whose expression is upregulated or downregulated following mechanical offloading in subjects with heart failure. The invention provides compositions comprising a targeting agent conjugated to a functional moiety, wherein the targeting agent selectively binds to a polypeptide encoded by one of these genes. The functional moiety can be an imaging agent, therapeutic agent, etc. The invention further provides methods for providing diagnostic or prognostic information related to heart failure involving detecting expression or activity of an expression product of one or more of the identified genes. The invention further provides diagnostic and therapeutic methods comprising detecting or administering an apelin peptide to a subject.
Apelin And Uses Thereof
Apelin And Uses Thereof
US Patent:
7947280, May 24, 2011
Filed:
Nov 14, 2007
Appl. No.:
11/985460
Inventors:
Euan A. Ashley - Palo Alto CA, US
Mary M. Chen - Fremont CA, US
Thomas Quertermous - Stanford CA, US
Mary M. Chen - Fremont CA, US
Thomas Quertermous - Stanford CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61K 39/00, C07K 4/00, C07K 4/12
US Classification:
4241851, 530327
Abstract:
The invention provides a method of treating or preventing heart failure or a disease or condition associated with heart failure comprising administering an effective dose of an apelin peptide or APJ receptor ligand to the subject. According to certain embodiments of the invention the apelin peptide is administered chronically. In certain embodiments of the invention the apelin peptide is administered in an amount effective to improve at least one hemodynamic parameter or prognostic variable for heart failure. Clinical conditions associated with heart failure include, but are not limited to, atherosclerosis, restenosis, ischemic cardiovascular diseases, idiopathic or viral cardiomyopathy, and the like.